Zenith Society The Alzheimer's Association

Why I Got Involved

Alzheimer's Association Champions and Zenith members share why they got involved with our mission.
Learn More

Darlene Shiley - Running time 2:38

How Association funds are used

How Association funds are used - pie chart

Learn More about the giving societies within the Alzheimer's Association.

Alzheimer's Association meets all 20 Better Business Bureau Charity Standards

Meet Zenith Society Co-Chairs Debbie and Clay Jones

View spread



(AAIC) Global Immersion Experience


Toronto, Canada

View highlights



Washington, D.C.

View highlights

Zenith Society Receptions and Meetings


San Francisco, CA

View photos
View 2015 meeting highlights

2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19


Annual Zenith Society Reception and Meeting
New York, NY

View photos
View 2013 meeting highlights

2 3 4 5 6 7 8 9 10 11 12 13 14


Annual Zenith Society Reception and Meeting
New York, NY

View photos

2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32


Zenith Fellows Award Winners

Thanks to the continued support and passion of the Zenith Society, four researchers from across the globe will each receive a three-year Zenith Fellows Award this year. Since its inception in 1991, the Zenith Society has provided nearly $40 million in Zenith Fellows grants to more than 130 leading Alzheimer’s disease researchers worldwide.

These grants support senior scientists who have contributed significantly to the field of Alzheimer's disease research and whose proposed projects are likely to make important new contributions to the Alzheimer's field. Thanks to the Zenith Society's generosity, they have helped to advance scientific knowledge of the causes of Alzheimer’s disease that can lead to effective treatment and our collective vision of a world without Alzheimer's.

The Zenith Society has a history of fostering cutting-edge research in Alzheimer’s disease and related dementias. In th projects below, the 2017 Fellows will address fundamental questions about the biology of Alzheimer’s and ways to prevent, diagnose or treat the disease. Detailed information about this funding is available here.

Bart DeStrooper, M.D., Ph.D. ($450,000 over three years)
Flanders Interuniversity Institute for Biotechnology (VIB)
, Leuven, Belgium
Project Title: Dissecting the Role of Human Astroglia in Alzheimer's Disease
Summary: How do specialized support cells in the brain called astroglia impact the onset and progression of Alzheimer's disease?

Kalipada Pahan, Ph.D. ($450,000 over three years)
Rush University Medical Center
, Chicago, Illinois
Project Title: PPARalpha in APP Metabolism
Summary: Can novel factors produced in the brain help prevent the formation of toxic beta-amyloid?

Ann-Marie Schmidt, M.D. ($450,000 over three years)
New York University School of Medicine
, New York, New York
Project Title: RAGE, DIAPH1, Microglia, and Alzheimer's Disease
Summary: How do immune cells from the blood enter and interact with specific brain cells to affect the progression of Alzheimer's disease?

Ruben Vidal, Ph.D. ($450,000 over three years)
Indiana University
, Indianapolis, Indiana
Project Title: In Vivo Analysis of Cell-Type-Specific Expression of Tau and Tau Spreading
Summary: What types of cells are involved in the formation and spread of abnormal tau protein in the brain during Alzheimer's disease?


Alzheimer's Association